Literature DB >> 10690503

Transferrin and transferrin receptor function in brain barrier systems.

T Moos1, E H Morgan.   

Abstract

1. Iron (Fe) is an essential component of virtually all types of cells and organisms. In plasma and interstitial fluids, Fe is carried by transferrin. Iron-containing transferrin has a high affinity for the transferrin receptor, which is present on all cells with a requirement for Fe. The degree of expression of transferrin receptors on most types of cells is determined by the level of Fe supply and their rate of proliferation. 2. The brain, like other organs, requires Fe for metabolic processes and suffers from disturbed function when a Fe deficiency or excess occurs. Hence, the transport of Fe across brain barrier systems must be regulated. The interaction between transferrin and transferrin receptor appears to serve this function in the blood-brain, blood-CSF, and cellular-plasmalemma barriers. Transferrin is present in blood plasma and brain extracellular fluids, and the transferrin receptor is present on brain capillary endothelial cells, choroid plexus epithelial cells, neurons, and probably also glial cells. 3. The rate of Fe transport from plasma to brain is developmentally regulated, peaking in the first few weeks of postnatal life in the rat, after which it decreases rapidly to low values. Two mechanisms for Fe transport across the blood-brain barrier have been proposed. One is that the Fe-transferrin complex is transported intact across the capillary wall by receptor-mediated transcytosis. In the second, Fe transport is the result of receptor-mediated endocytosis of Fe-transferrin by capillary endothelial cells, followed by release of Fe from transferrin within the cell, recycling of transferrin to the blood, and transport of Fe into the brain. Current evidence indicates that although some transcytosis of transferrin does occur, the amount is quantitatively insufficient to account for the rate of Fe transport, and the majority of Fe transport probably occurs by the second of the above mechanisms. 4. An additional route of Fe and transferrin transport from the blood to the brain is via the blood-CSF barrier and from the CSF into the brain. Iron-containing transferrin is transported through the blood-CSF barrier by a mechanism that appears to be regulated by developmental stage and iron status. The transfer of transferrin from blood to CSF is higher than that of albumin, which may be due to the presence of transferrin receptors on choroid plexus epithelial cells so that transferrin can be transported across the cells by a receptor-mediated process as well as by nonselective mechanisms. 5. Transferrin receptors have been detected in neurons in vivo and in cultured glial cells. Transferrin is present in the brain interstitial fluid, and it is generally assumed that Fe which transverses the blood-brain barrier is rapidly bound by brain transferrin and can then be taken up by receptor-mediated endocytosis in brain cells. The uptake of transferrin-bound Fe by neurons and glial cells is probably regulated by the number of transferrin receptors present on cells, which changes during development and in conditions with an altered iron status. 6. This review focuses on the information available on the functions of transferrin and transferrin receptor with respect to Fe transport across the blood-brain and blood-CSF barriers and the cell membranes of neurons and glial cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690503     DOI: 10.1023/a:1006948027674

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  104 in total

1.  Characterization and distribution of transferrin receptors in the rat brain.

Authors:  D C Mash; J Pablo; D D Flynn; S M Efange; W J Weiner
Journal:  J Neurochem       Date:  1990-12       Impact factor: 5.372

Review 2.  Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal.

Authors:  R D Broadwell
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Synthesis and localization of plasma proteins in the developing human brain. Integrity of the fetal blood-brain barrier to endogenous proteins of hepatic origin.

Authors:  K Møllgård; K M Dziegielewska; N R Saunders; H Zakut; H Soreq
Journal:  Dev Biol       Date:  1988-07       Impact factor: 3.582

4.  Brain-blood barrier? Yes and no.

Authors:  R D Broadwell; B J Balin; M Salcman; R S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

5.  Anemia of the Belgrade rat: evidence for defective membrane transport of iron.

Authors:  B J Bowen; E H Morgan
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

6.  Iron uptake by glial cells.

Authors:  K F Swaiman; V L Machen
Journal:  Neurochem Res       Date:  1985-12       Impact factor: 3.996

7.  Chloroquine reduces neuronal and glial iron uptake.

Authors:  K F Swaiman; V L Machen
Journal:  J Neurochem       Date:  1986-02       Impact factor: 5.372

8.  Synthesis of plasma proteins by rat fetal brain and choroid plexus.

Authors:  K M Dziegielewska; C A Evans; H New; M L Reynolds; N R Saunders
Journal:  Int J Dev Neurosci       Date:  1984       Impact factor: 2.457

9.  The distribution of plasma proteins in the neocortex and early allocortex of the developing sheep brain.

Authors:  M L Reynolds; K Møllgård
Journal:  Anat Embryol (Berl)       Date:  1985

10.  Increased accumulation of transferrin by motor neurons of the mouse mutant progressive motor neuronopathy (pmn/pmn).

Authors:  T Moos
Journal:  J Neurocytol       Date:  1995-05
View more
  84 in total

Review 1.  The nature and composition of the internal environment of the developing brain.

Authors:  K M Dziegielewska; G W Knott; N R Saunders
Journal:  Cell Mol Neurobiol       Date:  2000-02       Impact factor: 5.046

Review 2.  Pathogenic implications of iron accumulation in multiple sclerosis.

Authors:  Rachel Williams; Cassandra L Buchheit; Nancy E J Berman; Steven M LeVine
Journal:  J Neurochem       Date:  2011-11-11       Impact factor: 5.372

3.  Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury.

Authors:  En Huang; Wei-Yi Ong; Mei-Lin Go; James R Connor
Journal:  Exp Brain Res       Date:  2005-11-19       Impact factor: 1.972

4.  Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties.

Authors:  Lewis Zhichang Shi; G Jane Li; Shunzhen Wang; Wei Zheng
Journal:  Toxicol In Vitro       Date:  2007-07-28       Impact factor: 3.500

Review 5.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 6.  Blood-brain barrier transport of therapeutics via receptor-mediation.

Authors:  Angela R Jones; Eric V Shusta
Journal:  Pharm Res       Date:  2007-07-10       Impact factor: 4.200

Review 7.  Exposure, epidemiology, and mechanism of the environmental toxicant manganese.

Authors:  Pan Chen; Megan Culbreth; Michael Aschner
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-22       Impact factor: 4.223

8.  Deferoxamine attenuates acute hydrocephalus after traumatic brain injury in rats.

Authors:  Jinbing Zhao; Zhi Chen; Guohua Xi; Richard F Keep; Ya Hua
Journal:  Transl Stroke Res       Date:  2014-06-17       Impact factor: 6.829

9.  Diurnal cycle influences peripheral and brain iron levels in mice.

Authors:  Erica L Unger; Christopher J Earley; John L Beard
Journal:  J Appl Physiol (1985)       Date:  2008-11-06

10.  Iron is essential for neuron development and memory function in mouse hippocampus.

Authors:  Erik S Carlson; Ivan Tkac; Rhamy Magid; Michael B O'Connor; Nancy C Andrews; Timothy Schallert; Hiromi Gunshin; Michael K Georgieff; Anna Petryk
Journal:  J Nutr       Date:  2009-02-11       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.